GlobeNewswire by notified

PROPOSALS OF ROBIT PLC SHAREHOLDERS’ NOMINATION COMMITTEE FOR THE ANNUAL GENERAL MEETING 2023

Share

ROBIT PLC                          STOCK EXCHANGE RELEASE                                       18 JANUARY 2023 AT 11.30 AM

PROPOSALS OF ROBIT PLC SHAREHOLDERS’ NOMINATION COMMITTEE FOR THE ANNUAL GENERAL MEETING 2023

Robit Plc Shareholders’ Nomination Committee has prepared proposals on the Members of the Board of Directors and the remuneration of the Board of Directors for the Annual General Meeting 2023.

Number and Election of Board Members the Nomination


Committee proposes to the Annual General Meeting that six (6) Members will be elected to the Board of Directors.

The Nomination Committee proposes to the Annual General Meeting that the following persons be re-elected as the Members of the Board of Directors for the term ending at the close of the next Annual General Meeting: Mikko Kuitunen, Anne Leskelä, Harri Sjöholm, Markku Teräsvasara, Eeva-Liisa Virkkunen. Lasse Aho is proposed as a new member. Among the current members of the board Kim Gran has announced that he is no longer available when the board members are elected.

The resume of Lasse Aho, proposed as a new member, is attached to this release. Information on the proposed persons relevant to the work of the Board of Directors are available on the Company’s website https://www.robitgroup.com/investor/corporate-governance/board-of-directors/members-of-the-board/.

All nominees have given their consent to their election and are independent of the Company and its significant shareholders, except for Harri Sjöholm, who is dependent on a major shareholder. Harri Sjöholm is a major shareholder in Five Alliance Oy, which holds 27,06% percent of Robit Plc’s shares.

Remuneration of the Board of Directors

The Nomination Committee proposes to the Annual General Meeting that the annual remuneration of the Chairman of the Board of Directors is EUR 55,000, of which 40% is paid in shares and the remaining 60% is withholding tax, which the Company withholds and pays to the tax authorities. The annual remuneration of a Member of the Board of Directors is EUR 30,000, of which 40% is paid in shares and the remaining 60% is withholding tax, which the Company withholds and pays to the tax authorities.

In addition, the Nomination Committee proposes that the Members and Chairman of the Board of Directors will be paid for Board and Committee meetings a meeting fee of EUR 500 per meeting attended by them. If the meeting is organized remotely and its duration is max. 1 hour, paid meeting fee per meeting is EUR 250. In addition, travel, accommodation, and other expenses are reimbursed.

The annual remuneration for the entire term of office will be paid to the Members and Chairman of the Board of Directors in December 2023. The shares that form part of the remuneration payable to the Chairman of the Board and to the Board Members can be new shares issued by the Company or shares acquired thereby pursuant to an authorization provided to the Board of Directors by the General Meeting. The receiver of the remuneration will pay the applicable transfer tax.

The proposals of the Nomination Committee will be included in the notice to convene the Annual General Meeting.

The following persons serve on the shareholders’ Nomination Committee: Timo Sallinen, Head of Listed Securities, Varma Mutual Pension Insurance Company (Chairman), Harri Sjöholm, Chairman, Five Alliance Oy, Jukka Vähäpesola, Head of Equities, Elo Mutual Pension Insurance Company, and Markus Lindqvist director in charge of sustainability, Aktia Bank, as the other members.


ROBIT PLC

Harri Sjöholm
Chairman of the Board

Further information:
Harri Sjöholm, Chairman of the Board
+358 40 062 2092
harri.sjoholm@robitgroup.com

Distribution:
Nasdaq Helsinki Ltd
Key media
www.robitgroup.com

Robit is a strongly internationalized growth company servicing global customers and selling drilling consumables for applications in underground and surface mining, construction, geotechnical and well drilling. The company's offering is divided into two product and service ranges: Top Hammer and Down-the-Hole. Robit has own sales and service points in 9 countries as well as an active sales network in 100 countries. Robit’s manufacturing units are located in Finland, South Korea, Australia and the UK. Robit’s shares are listed on Nasdaq Helsinki Ltd. Further information is available at: www.robitgroup.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

EBC Financial Group (Cayman) Limited Granted Full Regulatory Licence from the Cayman Islands Monetary Authority (CIMA)28.3.2024 11:53:45 CET | Press release

EBC Financial Group strengthens its global presence with full CIMA licence, underscoring the group’s commitment to stringent global regulatory standards HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC Group or EBC) is pleased to announce that its Cayman Islands subsidiary, EBC Financial Group (Cayman) Limited, has been awarded a full Cayman Islands Monetary Authority (CIMA) licence. This significant achievement marks a major advancement in EBC's global regulatory portfolio, following its existing accreditations from the UK's Financial Conduct Authority (FCA) and the Australian Securities and Investments Commission (ASIC). Within CIMA's strict regulatory framework, EBC will offer more comprehensive financial services, including trusts, securities, futures, and funds, specifically catering to retail, professional, high-net-worth individuals and institutional investors. The Cayman Islands, recognized as a premier offshore financial centre, gathers 90% of the world's

Changes in financial calender28.3.2024 11:30:00 CET | Press release

According to the AS Pro Kapital Grupp 2024 financial calendar, the Company should publish its audited financial results for 2023 on 30 April 2024. AS Pro Kapital Grupp announces that it will publish its audited financial results for 2023 earlier than foreseen in the Company's financial calendar and the audited results for 2023 will be published between 10-12 April 2024. Ann-Kristin Kuusik CFO Phone: +372 614 4920 e-mail: prokapital@prokapital.ee

Meriaura Group Plc’s annual report for 2023 published28.3.2024 11:30:00 CET | Press release

Meriaura Group Plc Company Announcement 28 April 2024 at 11.30 a.m. (CET) Meriaura Group Plc’s annual report for 2023 published Meriaura Group Plc’s annual report including the annual accounts, the report of the Board of Directors and the auditor’s report for the year 2023 has been published. The annual report is available at the company’s website https://meriauragroup.com/investors/reports-and-presentations/financial-reports/ and it’s also attached to this announcement. The annual report is available in pdf format in Finnish and in English. MERIAURA GROUP PLC Further information: CEO Kirsi Suopelto Tel: +358 505 602 349 Email: kirsi.suopelto@meriaura.com Meriaura Group in brief Meriaura Group has two business areas: Marine Logistics and Renewable Energy. Marine Logistics business is carried out by Meriaura Ltd, which is a major provider of transport for bulk cargo and demanding project deliveries in Northern Europe, especially in the Baltic Sea and North Sea regions. The company provi

Calibre Enters Pre-Commissioning and Commissioning Contract with Reliable Controls Corporation and Executes A Gold Prepayment28.3.2024 11:00:16 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce the Company has entered into a key pre-commissioning and commissioning contract with Reliable Controls Corporation of Salt Lake City (“RCC”) for the Company’s Valentine Gold Mine (“VGM”) in Newfoundland and Labrador. The Company has also executed a US$60 million short term, gold prepayment agreement with Asahi Refining USA Inc. (“Asahi”), pursuant to which Asahi has agreed to purchase a total of 27,600 ounces of gold from the Company, comprising less than 10% of the Company’s expected 2024 gold production. Darren Hall, President and Chief Executive Officer of Calibre, stated: “With construction at Valentine 61% complete I remain confident in our ability to deliver first gold during H1, 2025. To further derisk delivery, I am pleased to announce that we have secured RCC, a team of highly experienced commissioning experts to lead

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors28.3.2024 11:00:00 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to its board of directors effective April 2, 2024. “Dr. Gallagher is the sixth director to join our board of directors in the past twelve months as we continue to refresh and strengthen the Board governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. “His experience and leadership in leading multiple development programs through to global regulatory approval will support our efforts to rapidly advance our ‘5 by 5’ programs into clinical studies and our continued pipeline expansion of novel antibody-drug conjugates and multispecific antibodies in the years a

HiddenA line styled icon from Orion Icon Library.Eye